PERCEPTIVE ADVISORS LLC - 14 Aug 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Security
CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
CTMX
Shares outstanding
164,070,932 shares
Disclosed Ownership
9,680,185 shares
Ownership
5.9%
Form type
SCHEDULE 13G
Filing time
21 Aug 2025, 16:00:03 UTC
Date of event
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 5.9% 9,680,185 0 9,680,185 /s/ Joseph Edelman Joseph Edelman, Managing Member
Joseph Edelman 5.9% 9,680,185 0 9,680,185 /s/ Joseph Edelman Joseph Edelman
Perceptive Life Sciences Master Fund, Ltd. 5.9% 9,680,185 0 9,680,185 /s/ Joseph Edelman Joseph Edelman, Managing Member